Real-World experience of interictal burden and treatment in migraine: a qualitative interview study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Real-World experience of interictal burden and treatment in migraine: a qualitative interview study ; volume:23 ; number:1 ; day:8 ; month:6 ; year:2022 ; pages:1-10 ; date:12.2022
The journal of headache and pain ; 23, Heft 1 (8.6.2022), 1-10, 12.2022
- Urheber
-
Lo, Siu Hing
Gallop, Katy
Smith, Timothy
Powell, Lauren
Johnston, Karissa
Hubig, Lena T.
Williams, Emma
Coric, Vladimir
Harris, Linda
L’Italien, Gilbert
Lloyd, Andrew J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-022-01429-5
- URN
-
urn:nbn:de:101:1-2022080519315681879364
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lo, Siu Hing
- Gallop, Katy
- Smith, Timothy
- Powell, Lauren
- Johnston, Karissa
- Hubig, Lena T.
- Williams, Emma
- Coric, Vladimir
- Harris, Linda
- L’Italien, Gilbert
- Lloyd, Andrew J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany
Real-World Heart Failure Burden in Thai Patients
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience
Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study
Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application
A prospective real-world analysis of erenumab in refractory chronic migraine
A Prospective Real-World Study Exploring Associations Between Passively Collected Tracker Data and Headache Burden Among Individuals with Tension-Type Headache and Migraine
Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany
Real-World Heart Failure Burden in Thai Patients
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience
Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study
Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application
A prospective real-world analysis of erenumab in refractory chronic migraine
A Prospective Real-World Study Exploring Associations Between Passively Collected Tracker Data and Headache Burden Among Individuals with Tension-Type Headache and Migraine
Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany
Real-World Heart Failure Burden in Thai Patients
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience
Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study
Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application
A prospective real-world analysis of erenumab in refractory chronic migraine